Equities
Health CareHealth Care Providers
  • Price (JPY)1,495.00
  • Today's Change4.00 / 0.27%
  • Shares traded3.56m
  • 1 Year change-36.57%
  • Beta1.2507
Data delayed at least 15 minutes, as of Dec 03 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year M3 Inc had net income fall -7.66% from 49.03bn to 45.27bn despite a 3.49% increase in revenues from 230.82bn to 238.88bn. An increase in the selling, general and administrative costs as a percentage of sales from 25.56% to 28.32% was a component in the falling net income despite rising revenues.
Gross margin57.52%
Net profit margin17.35%
Operating margin23.72%
Return on assets9.03%
Return on equity11.50%
Return on investment10.81%
More ▼

Cash flow in JPYView more

In 2024, M3 Inc increased its cash reserves by 26.49%, or 31.34bn. The company earned 58.31bn from its operations for a Cash Flow Margin of 24.41%. In addition the company generated 9.43bn cash from financing while 39.46bn was spent on investing.
Cash flow per share77.67
Price/Cash flow per share19.17
Book value per share514.76
Tangible book value per share298.90
More ▼

Balance sheet in JPYView more

M3 Inc has a Debt to Total Capital ratio of 6.28%.
Current ratio3.72
Quick ratio--
Total debt/total equity0.0699
Total debt/total capital0.0628
More ▼

Growth rates in JPY

Year on year, growth in dividends per share increased 10.53% while earnings per share excluding extraordinary items fell by -7.68%. The positive trend in dividend payments is noteworthy since very few companies in the Software & Programming industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.37%
Div growth rate (5 year)24.57%
Payout ratio (TTM)36.41%
EPS growth(5 years)17.14
EPS (TTM) vs
TTM 1 year ago
-19.10
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.